Increased c-myc oncogene expression in Ewing's sarcoma: Correlation with Ki67 proliferation index

Tumori

Volumn 85, Issue 3, 1999, Pages 167-173

  Sollazzo, Maria Rosa ^a   Benassi, Maria Serena ^a   Magagnoli, Giovanna ^a   Gamberi, Gabriella ^a   Molendini, Lara ^a   Ragazzini, Paola ^a   Merli, Mara ^a   Ferrari, Cristina ^a   Balladelli, Alba ^a   Picci, Piero ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

c myc; Ewing's sarcoma; Ki67

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EWING SARCOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METASTASIS; ONCOGENE C MYC; PROTEIN EXPRESSION;

EID: 0032807399     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169908500304     Document Type: Article

References (38)

1. Barrios C., Castresana J.S., Ruiz J., Kreicbergs A.: Amplification of c-myc oncogene and absence of c-Ha-ras point mutations in human bone sarcomas. J. Orthop. Res., 11: 556-563, 1993.
2. Barrios C., Castresana J.S., Kreicbergs A.: Clinicopathologic correlations and short-term prognosis in musculoskeletal sarcoma with c-myc oncogene amplification. Am. J. Clin. Oncol., 17:273-276, 1994.
3. Barrios H., Castresana J.S., Ruiz J., Kreicbergs A.: Amplification of the c-myc proto-oncogene in soft tissue sarcomas. Oncology, 51: 13-17, 1994.
4. Barnard M.J., Hall P.A., Lemoine N.R., Kadar N.: Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J. Pathol., 152: 287-295, 1987.
5. Blackwood E.M., Eiseman J.K.: Max: an helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with myc. Science, 250: 1149-1151, 1991.
6. Campanacci M: Tumors of the soft tissues. In: Bone and soft tissue tumors, Gaggi A. (Ed.), pp 841-1060, Springer-Verlag, Vienna, New York, 1990.
7. Cavazzana A., Miser J., Jefferson J., Triche T.: Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am. J. Pathol., 127: 507-518, 1987.
8. Cavazzana A., Magnani M., Ross R.: Ewing's sarcoma is an undifferentiated neuroectodermal tumor. Prog. Clin. Biol. Res., 271: 577-583, 1988.
9. Christine F., Stephenson D., Julia A., Bridge M., Sandberg A.: Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors. Hum. Pathol., 23: 1270-1277, 1992.
10. Collins S., Groudine M.: Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature, 298: 679-681, 1982.
11. Dalla-Favera R., Wong-Staal F., Gallo R.C.: Oncogene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patients. Nature, 229: 61-63, 1982.
12. Fellinger E., Garin-Chesa P., Triche T., Huvos A., Rettig W.: Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32. Am. J. Pathol., 139: 317-325, 1991.
13. Gamberi G., Benassi M., Ferrari C., Ragazzini P., Sollazzo M., Molendini L., Sangiorgi L., Picci P.: Additional methods of diagnosis in the histopathology of the musculoskeletal system. Chir. Org. Mov., LXXX: 417-426, 1995.
14. Granowetter L.: Ewing's sarcoma. Curr. Opin. Oncol., 3: 684-688, 1991.
15. Hall P.A., Richards M.A., Gregory W.M., D'Ardenne A.J., Lister T.A., Stansfeld A.G.: The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J. Pathol., 154: 223-235, 1988.
16. Hamel P., Gill R., Phillips R., Gallie B.: Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by product of the RB1 gene. Mol. Cell. Biol., 12: 3431-3438, 1992.
17. Jansen-Durr P., Meichle A., Steiner P., Pagano M., Finke K., Botz J., Wessbecher J., Draetta G., Eilers M.: Differential modulation of cyclin gene expression by myc. Proc. Natl. Acad. Sci., 90: 3685-3689, 1993.
18. Kelly K., Cochran B., Stiles C., Leder P.: Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell, 35: 603-610, 1983.
19. Klein G., Klein E.: Conditioned tumorigenicity of activated oncogenes. Cancer Res., 46: 3211-3224, 1986.
20. Kroese M., Rutgers D., Wils I., Van Unnik J., Roholl P.: The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer, 65: 1783-1788, 1990.
21. Ladanyi M., Heinemann F., Huvos A., Rao P., Chen Q., Jhanwar S.: Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t (11;22) (q24;q12). Hum, Pathol., 21: 1245-1251, 1990.
22. Liombart-Bosch A., Lacombe M., Contesso G.: Small round cell sarcoma of bone mimicking atypical Ewing's sarcoma with neuroectodermal features. Cancer, 60: 1570-1582, 1987.
23. Meyer J.: Growth and cell kinetics measurements in human tumors. Pathol. Ann., 16: 53-80, 1981.
24. Nevins J.R.: E2F: a link between the RB tumor suppressor protein and viral oncoproteins. Science, 258: 424-429, 1992.
25. O'Connor M.I., Pritchard D.J.: Ewing's sarcoma. Prognostic factors, disease control, and the reemerging role of surgical treatment. Clin. Orthop., 262: 78-87, 1991.
26. Pavelic Z., Pavelic L., Lower E., Gapany M., Gapany S., Barker E.: C-myc, c-erbB2 and Ki67 expression in normal breast tissue and in invasive and non invasive breast carcinoma. Cancer Res., 52: 2597-2602, 1992.
27. Picci P., Bohling T., Bacci G., Ferrari S., Sangiorgi L., Mercuri M., Ruggieri P., Manfrini M., Ferraro A., Casadei R., Benassi M., Mancini A., Rosito P., Cazzola A., Barbieri E., Tienghi A., Brach del Prever A., Comandone A., Bacchini P., Bertoni F.: Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J. Clin. Oncol., 15: 1553-1559, 1997.
28. Quinn C., Wright N.: The clinical assessment of proliferation and growth in human tumors: evaluation of methods and applications as prognostic variable. J. Pathol., 160: 93-102, 1990.
29. Sheiness D., Bishop J.M.: DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J. Virol., 31: 465-475, 1987.
30. Shin D.M., Gupta V., Donner L., Chawla S., Benjamin R., Gutterman J., Blick M.: Abberant oncogene expression in uncultured human sarcoma and melanoma. Anticancer Res., 7: 1117-1123, 1987.
31. Silvestrini R., Daidone M., Costa A.: Cell kinetic of solid tumors with time and its clinical implication. Tumori, 75: 367-372, 1989.
32. Tatosyan A.G., Galetzki S.A., Kisseljova N.P.: Oncogene expression in human tumors. Int. J. Cancer, 35: 731-736, 1985.
33. Triche T., Cavazzana A.: Round cell tumor of bone. In: Bone tumors, Unni K.K. (Ed.), Churchill Livingstone, New York, 1988.
34. Turc-Carel C., Philip I., Berger M.: Chromosome study of Ewing's sarcoma (ES) cell lines: Consistency of reciprocal translocation t(11;22) (q24C2). Cancer Genet. Cytogenet., 12: 1-19, 1984.
35. Ushigome S., Shimoda T., Takaki K., Nikaido T., Takakuwa T., Ishikawa E., Spjut H.: Immunocytochemical and ultrastructural studies of the histogenesis of Ewing's sarcoma and putatively related tumors. Cancer, 64: 52-62, 1989.
36. Ueda T., Aozasa K., Tsujimoto M., Ohsawa M., Uchida A., Aoki Y.: Prognostic significance of Ki67 reactivity in soft tissue sarcomas. Cancer, 63: 1607-1611, 1989.
37. Whang-Peng J., Triche T., Knutsen T: Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet. Cytogenet., 21: 185-208, 1986.
38. Zutter M., Krigman H., Santoro S.: Altered integrin expression in adenocarcinoma of the breast. Am. J. Pathol., 142: 1439-1448, 1993.